Drug Therapy of Gout.

Slides:



Advertisements
Similar presentations
GOUT Disease caused by tissue deposition of Monosodium urate crystals as a result of supersatuaration of extra cellular fluid with MSU.
Advertisements

Copyright © 2015 Cengage Learning® Chapter 15 Urinary System Drugs.
Purine degradation & Gout (Musculoskeletal Block) Purine degradation pathway Fate of uric acid in humans Gout and hyperuricemia: Biochemistry Types Treatment.
{ Gout and Bursitis Asfand Baig.   Inflammatory arthritis associated with hyperuricaemia* and intra-articular sodium urate crystals Gout.
Purine Degradation & Gout (Musculoskeletal Block)
Prepared by : Tamara Odeh Diana Jawhari Supervised by : Dr. Ola Ayesh.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 74 Drug Therapy of Gout.
Gout.
 Gout is characterized by elevated uric acid concentrations in blood and urine due to variety of metabolic abnormalities that include overproduction.
GOUT. OBJECTIVES At the end of lectures students should : Define gout Describe outlines of treatment Describe treatment of acute gouty arthritis Describe.
PHCL 424 Management Gout Ahmed Shaman Clinical Pharmacy Department KSU 1.
Reginald D Sanders, MD LSU Clinical Pharmacology Drug Therapy of Gout.
Uric Acid Metabolism & Gout. Nucleic Acids Mononucleotide Base + Sugar + Phosphoric Acid Base: Purine or Pyrimidine Polynucleotide (DNA or RNA) Mononucleotides.
Purine degradation & Gout (Musculoskeletal Block).
Gout Dr. Wael H.Mansy, MD Assistant Professor College of Pharmacy King Saud University.
Familial metabolic disease Characterized by : Acute arthritis Uric stones in the kidneys Hyperuricemia.
GOUT. By Prof. Azza El- Medany Dr. Osama Yousf OBJECTIVES At the end of lectures students should : Define gout Describe outlines of treatment Describe.
Chapter 13 Agents Used to Treat Hyperuricemia and Gout.
Uric Acid Metabolism & Gout. Nucleic Acids Mononucleotide Base + Sugar + Phosphoric Acid Base: Purine or Pyrimidine Polynucleotide (DNA or RNA) Mononucleotides.
Gout By Shravya & Helen. Gout is… An inflammatory arthritis associated with hyperuricaemia and intra-articular sodium urate crystals.
GOUT. OBJECTIVES At the end of lectures students should : Define gout Describe outlines of treatment Describe treatment of acute gouty arthritis Describe.
Uric Acid Metabolism & Gout
GOUT. By Prof. Azza El- Medany Dr. Osama Yousf OBJECTIVES At the end of lectures students should : Define gout Describe outlines of treatment Describe.
GOUT. By Prof. Azza El- Medany Dr. Osama Yousf OBJECTIVES At the end of lectures students should : Define gout Describe outlines of treatment Describe.
Anti-Inflammatory & Immunosuppressive Drugs 2
Gout Familial metabolic disease characterized by : Acute arthritis Uric acid stones in the kidneys Hyperuricemia.
Drug therapy of gout - overview what is gout? what happens to patients with gout & why? what drugs are available for managing gout? how are those drugs.
GOUT.
Gout Gouty Arthritis By Mike Parenteau.
Clinical Case #6 By Chen, chun-Yu (Kim) Chen, I -chun (Afra) Chen, I -chun (Afra)
Four Stages of Gout  Asymptomatic hyperuricemia Elevated levels of uric acid in the blood but no other symptoms Does not require treatment  Acute gout/Acute.
CHAPTER © 2012 The McGraw-Hill Companies, Inc. All rights reserved. 20 Nonopioid Analgesics, Nonsteroidal Antiinflammatories, and Antigout Drugs.
Gout Familial metabolic disease characterized by : Acute arthritis Uric acid stones in the kidneys Hyperuricemia.
GOUT. Demographics Affects middle-aged to elderly men postmenopausal and elderly women (usually have OA and HPN causing mild renal insufficiency, and.
Agents Used to Treat Hyperuricemia and Gout
GOUT A metabolic disease in which tissue deposition of crystals of monosodium urate occurs from supersaturated extracellular fluids and results in one.
GOUT: DIAGNOSIS AND MANAGEMENT. Gout Metabolic disorder due to excessive accumulation of uric acid in tissues leading to acute and chronic arthritis and.
Drug Therapy of Gout. Drug therapy of gout What Is Gout?
Gout Treatment Megan Chan, PGY-2 UHCMC Gout Acute gouty arthritis = monosodium urate crystals in synovial fluid leukocytes – Serum urate ≥ 6.8 =
Gout. The most common cause of inflammatory arthritis in US adults (3.9% of Americans; approx. 8.3 million people; ) Prevalence is greater in.
StagesClinical Features (1)Asymptomatic hyperuricemiahigh uric acid level is present but without symptoms (2) Acute Gouty Arthritishigh uric acid level.
GOUTY ARTHRITIS PRESENTED BY, JISMI MATHEW LINCY K OUSEPH MEENUPRIYA OONNANAL SMITHA V CHACKO VINEETHA MARY MATHEW.
GOUTY ARTHRITIS PRESENTED BY, JISMI MATHEW LINCY K OUSEPH MEENUPRIYA OONNANAL SMITHA V CHACKO VINEETHA MARY MATHEW.
Gout Pharmacotherapies Joseph Kitzmiller MD PhD FCP 5086 Graves Hall Assistant Professor – Biological Chemistry & Pharmacology
ANTI-GOUT DRUGS. GOUT A familial metabolic disease characterized by recurrent episodes of acute arthritis due to deposits of monosodium urate in joints.
Drugs in gout epidemiology Male to female ration 10:1 Prevalence of hyperuricemia 5% Prevalence of gout 0.2%
Purine Degradation & Gout (Musculoskeletal Block) Purine degradation pathway Fate of uric acid in humans Gout and hyperuricemia: Biochemistry Types Treatment.
Metabolism of purine nucleotides A- De Novo synthesis: of AMP and GMP Sources of the atoms in purine ring: N1: derived from NH2 group of aspartate C2 and.
Gout Ashley Guzman Primary Care I: Acute and Chronic Health Problems
Crystalopathies Joanna Zalewska.
Gout Is recurrent inflammatory disorder characterized by
Gout.
Drugs in gout epidemiology Prevalence of hyperuricemia 5%
Introduction to pathology
Drugs in gout.
Drug Therapy of Gout 1.
GOUT.
Gout and Hyperuricaemia
Antiuricaemic drugs Dr A.W Olusanya.
Lecture 9 Musculoskeletal Disorders Gout
Your Patient 50 years old male comes in the emergency complaining severe pain in his big toe and ankle for the last 12 hrs. On examination joint shows.
Gout Scott Smith PGY-1 1/11/2018.
Purine Degradation & Gout (Musculoskeletal Block)
Drugs in gout epidemiology Prevalence of hyperuricemia 5%
Drugs in gout.
Purine Degradation & Gout (Musculoskeletal Block)
Presentation transcript:

Drug Therapy of Gout

What Is Gout? A medical condition caused by an increase in the level of uric acid >> urate crystals , causing inflammatory responses around some joints of the body ( Gouty arthritis )

Case presentation ( Gouty arthritis) 55 y/o male 12 hours “pain in my big toe & ankle” went to bed last night feeling fine felt as if had broken toe this morning PMH of similar problems in right ankle & left wrist

acute synovitis, ankle & first MTP joints Gout - acute arthritis acute synovitis, ankle & first MTP joints Redness and swelling are noticed around those joints in particular The metatarsophalangeal articulations are the joints between the metatarsal bones of the foot and the proximal bones

Gout - acute bursitis acute olecranon bursitis Bursitis is inflammation of the fluid-filled sac (bursa) that lies between a tendon and skin, or between a tendon and bone

Gouty arthritis - characteristics sudden onset middle aged males severe pain distal joints Intense inflammation recurrent episodes influenced by diet ( since uric acid level is influenced by our dietary intake of purines) bony erosions on Xray

Monosodium urate crystals 1-polarized light 2-red compensator These crystals show : 1-needle shape 2-negative birefringence (Birefringence: double streams of light, usually in prisms, etc) Diagnosis is done by taking a biopsy from the synovial fluid and then examined either by:

Crystal-induced inflammation (from gout to gouty arthritis ) crystal deposition (blood stream) hyperuricemia protein binding receptor binding (Synovial joints ) cytokine release influx of PMN’s (Macrophages ) crystals engulfed inflammation PMN is critical component of crystal-induced inflammation

Gouty arthritis - characteristics sudden onset middle aged males severe pain distal joints intense inflammation recurrent episodes influenced by diet bony erosions on Xray Hyperuricemia (always)

Hyperuricemia excretion production hyperuricemia results when production exceeds excretion (either by over production or less excretion )

net uric acid loss results when excretion exceeds production Hyperuricemia production excretion net uric acid loss results when excretion exceeds production

Chronic tophaceous gout tophus = localized deposit of monosodium urate crystals ** could also be in several places in the body

classic location of tophi on helix of ear Gout - tophus classic location of tophi on helix of ear

Gout - X-ray changes DIP (Distal interphalangeal joint) joint destruction phalangeal bone cysts

Gout - X-ray changes bony erosions

Gout - cardinal manifestations arthritis tophi chronic acute & chronic HYPERURICEMIA Nephrolithiasis (Kidney stones) nephropathy *kidneys should be functioning well in order to use classical treatment

Drug therapy of gout Treatment targets either : 1- Decrease Uric Acid Formation 2- Increase Uric Acid Excretion

The Role of Uric Acid in Gout end product of purine metabolism serum uric acid level dependent upon rate of uric acid production efficiency of renal uric acid excretion

Uric acid metabolism cell breakdown dietary intake purine bases hypoxanthine xanthine oxidase catalyzes hypoxanthine to xanthine & xanthine to uric acid One method of reducing uric acid levels , is inhibition of the enzyme xanthine oxidase xanthine uric acid

Renal handling of uric acid Fate of uric acid in kidneys : Uric acid glomerular filtration tubular reabsorption tubular excretion post-secretory reabsorption net excretion Uric acid Uric acid Uric acid The goal of some Gout Drugs, is to Increase the net excretion of uric acid from the kidneys.

The goal of some Gout Drugs, is to Increase the net excretion of uric acid from the kidneys Non steroidal anti-inflammatory Drugs are sometimes used in the treatment of Gout ( cause increase in excretion ) Aspirin on the other hand is never used

Gout - problems excessive total body levels of uric acid deposition of monosodium urate crystals in joints & other tissues crystal-induced inflammation

Treating acute gouty arthritis colchicine NSAID’s steroids rest, analgesia, ice, time

Drugs used to treat gout Urate Lowering Drugs For chronic cases Acute Arthritis Drugs steroids NSAID’s colchicine allopurinol probenecid febuxostat? It’s a new drug that’s being developed rest + analgesia + time

Drugs used to treat gout NSAID’s Indomethacin (Indocin) 25 to 50 mg four times daily Naproxen (Naprosyn) 500 mg two times daily Ibuprofen (Motrin) 800 mg four times daily Sulindac (Clinoril) 200 mg two times daily Ketoprofen (Orudis) 75 mg four times daily *Don’t memorize the doses, just the names ** Remember that Aspirin is never used

Colchicine - plant alkaloid colchicum autumnale (autumn crocus or meadow saffron)

Correction for the previous lecture Colchicine is used to prevent the polymerization of the cell’s cytoskeleton by binding to TUBULIN ( not Actin)

Colchicine “only effective in gouty arthritis” ( it only works on the inflammation process , and has nothing to do with uric acid levels .) not an analgesic does not affect renal excretion of uric acid does not alter plasma solubility of uric acid neither raises nor lowers serum uric acid

Colchicine Colchicine inhibits microtubule polymerization by binding to tubulin, one of the main constituents of microtubules reduces inflammatory response to deposited crystals diminishes PMN phagocytosis of crystals blocks cellular response to deposited crystals

Crystal-induced inflammation crystal deposition hyperuricemia protein binding receptor binding cytokine release influx of PMN’s crystals engulfed inflammation PMN is critical component of crystal-induced inflammation

Colchicine - indications Dose Indication high treatment of acute gouty arthritis low prevention of recurrent gouty arthritis It’s better to use xanthine oxidase inhibitors for

Colchicine - toxicity Associated with high doses : gastrointestinal (nausea, vomiting, cramping, diarrhea, abdominal pain) hematologic (agranulocytosis, aplastic anemia, thrombocytopenia) muscular weakness adverse effects dose-related & more common when patient has renal or hepatic disease

Gout - colchicine therapy more useful for daily prophylaxis (low dose) prevents recurrent attacks colchicine 0.6 mg qd - bid declining use in acute gout (high dose)

Colchicine - Cancers Promising studies have recently shown that Colchicine could be used for treating tumors HOW ? Since Colchicine prevents the formation of microtubules , this could be useful in limiting the mitotic activity of tumors cell : by preventing the formation of mitotic spindles (microtubules .)

Hyperuricemia - mechanisms excessive production inadequate excretion

net reduction in total body pool of uric acid Urate-lowering drugs block production enhance excretion net reduction in total body pool of uric acid

Gout - urate-lowering therapy Xanthine Oxidase as an example prevents arthritis, tophi & stones by lowering total body pool of uric acid not indicated after first attack initiation of therapy can worsen or bring on acute gouty arthritis no role to play in managing acute gout

Drugs That Block Production of Uric Acid Drug therapy of gout Drugs That Block Production of Uric Acid

Uric acid metabolism cell breakdown dietary intake purine bases hypoxanthine xanthine oxidase catalyzes hypoxanthine to xanthine & xanthine to uric acid xanthine uric acid

Allopurinol (Zyloprim™) inhibitor of xanthine oxidase effectively blocks formation of uric acid how supplied - 100 mg & 300 mg tablets pregnancy category C **Drugs are characterized according to their effects on pregnancy (fetus) into several categories A,B,C,D,X. A is the safest, X: completely dangerous and should not be given to pregnant women  **benefits from taking the drug must outweigh it’s risks in order for it to be used. allopurinol

Allopurinol - usage indications management of hyperuricemia of gout management of hyperuricemia associated with chemotherapy prevention of recurrent calcium oxalate kidney stones

Allopurinol - common reactions diarrhea, nausea, abnormal liver tests acute attacks of gout rash *Manufactures are obliged to put a special indication on each leaflet ( a BLACK BOX) , that explains the serious side effect for that particular drug e.g Isotretinoin is a highly teratogenic Drug that should have a BLACK BOX **For Allopurinol you might find that BLACK BOX sometimes , because certain people have shown to have allergy for it .

Allopurinol - serious reactions fever, rash, toxic epidermal necrolysis hepatotoxicity, marrow suppression vasculitis drug interactions (ampicillin(antibiotic), thiazides(diuretic ), mercaptopurine, azathioprine(anti-cancer) death

Stevens-Johnson syndrome Another serious side effect , characterized by : Mucocutaenous ulcerations target skin lesions mucous membrane erosions epidermal necrosis with skin detachment Those side effects are treated by systemic corticosteroids

Allopurinol hypersensitivity extremely serious problem prompt recognition required first sign usually skin rash more common with impaired renal function progression to toxic epidermal necrolysis & death

Febuxostat recently approved by FDA (not on market) oral xanthine oxidase inhibitor chemically distinct from allopurinol 94% of patients reached urate < 6.0 mg/dl minimal adverse events can be used in patients with renal disease

PEG-uricase (Polyethelene Glycol) Uricase: enzyme that degrades uric acid  investigational drug PEG-conjugate of recombinant porcine uricase treatment-resistant gout uricase speeds resolution of tophi further research needed

Drugs That Enhance Excretion of Uric Acid Drug therapy of gout Drugs That Enhance Excretion of Uric Acid

Uricosuric therapy probenecid blocks tubular reabsorption of uric acid enhances urine uric acid excretion increases urine uric acid level decreases serum uric acid level

Uricosuric therapy moderately effective increases risk of nephrolithiasis not used in patients with renal disease frequent, but mild, side effects

Uricosuric therapy contra-indications history of nephrolithiasis elevated urine uric acid level existing renal disease less effective in elderly patients

Choosing a urate-lowering drug hyperuricemia excessive production inadequate excretion xanthine oxidase inhibitor uricosuric agent

Refer to the third slide Drug therapy of gout Case Presentation Refer to the third slide

Case presentation - therapy NSAID steroid NSAID colchicine (low-dose) Maintenance dose Anti-inflammatory allopurinol Chronic condition days 1-10 days 11-365 days 365+

Done by Anas Khalil With the help of shaima shahin’s Notes